Toggle Sidebar
Home
AI Agent
Annotations
Watchlists
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
KLAC US
Kla Corp
(KLAC US)
$145.61
-2.22
1.50%
Ext:
$145.89
+0.28
0.20%
(Market Closed · 00:00:00 UTC)
Follow
Financials & Metrics
Financials
Charting
Short Interest
Employees
SEC Filings
Select Filings
Financials
(139)
Expand
10-K
FY 2026
ended 30 Jun 2026
6 Aug
10-Q
Q3
ended 31 Mar 2026
29 Apr
10-Q
Q2
ended 31 Dec 2025
30 Jan
10-Q
Q1
ended 30 Sept 2025
31 Oct 2025
10-K
FY 2025
ended 30 Jun 2025
8 Aug 2025
10-Q
Q3
ended 31 Mar 2025
1 May 2025
10-Q
Q2
ended 31 Dec 2024
31 Jan 2025
10-Q
Q1
ended 30 Sept 2024
31 Oct 2024
10-K
FY 2024
ended 30 Jun 2024
5 Aug 2024
10-Q
Q3
ended 31 Mar 2024
26 Apr 2024
10-Q
Q2
ended 31 Dec 2023
26 Jan 2024
10-K
FY 2023
ended 30 Jun 2023
4 Aug 2023
10-Q
Q3
ended 31 Mar 2023
28 Apr 2023
10-Q
Q2
ended 31 Dec 2022
27 Jan 2023
10-Q
Q1
ended 30 Sept 2022
28 Oct 2022
Events
(337)
Expand
8-K
Investor Relations:Media Relations:Kevin Kessel, CFAMike DulinVice President, Investor RelationsCorporate Communications(408)
[email protected]
@kla.com
6 Aug
8-K
Results of Operations and Financial Condition
28 Jul
8-K
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
12 Jun
8-K
Investor Relations:Media Relations:Kevin Kessel, CFAMike DulinVice President, Investor RelationsCorporate Communications(408)
[email protected]
@kla.com
7 May
8-K
Results of Operations and Financial Condition
29 Apr
8-K
Regulation FD Disclosure
12 Mar
8-K
Investor Relations:Media Relations:Kevin Kessel, CFAMike DulinVice President, Investor RelationsCorporate Communications(408)
[email protected]
@kla.com
5 Feb
8-K
Results of Operations and Financial Condition
29 Jan
8-K
Investor Relations:Media Relations:Kevin Kessel, CFAMike DulinVice President, Investor RelationsCorporate Communications(408)
[email protected]
@kla.com
7 Nov 2025
8-K
Results of Operations and Financial Condition
29 Oct 2025
8-K
Investor Relations:Media Relations:Kevin Kessel, CFAMike DulinVice President, Investor RelationsCorporate Communications(408)
[email protected]
@kla.com
7 Aug 2025
8-K
Results of Operations and Financial Condition
31 Jul 2025
8-K
Entry into Material Agreement
8 Jul 2025
8-K
Investor Relations:Media Relations:Kevin Kessel, CFAMike DulinVice President, Investor RelationsCorporate Communications(408)
[email protected]
@kla.com
8 May 2025
8-K
Director/Officer Changes & Compensatory Arrangements
1 May 2025
Insider Ownership
(1.6K)
Expand
4
Statement of changes in beneficial ownership
16 Sep
4
Statement of changes in beneficial ownership
14 Aug
4
Statement of changes in beneficial ownership
13 Aug
4
Statement of changes in beneficial ownership
12 Aug
4
Statement of changes in beneficial ownership
12 Aug
4
Statement of changes in beneficial ownership
11 Aug
4
Statement of changes in beneficial ownership
11 Aug
4
Statement of changes in beneficial ownership
10 Aug
4
Statement of changes in beneficial ownership
10 Aug
4
Statement of changes in beneficial ownership
10 Aug
4
Statement of changes in beneficial ownership
10 Aug
4
Statement of changes in beneficial ownership
10 Aug
4
Statement of changes in beneficial ownership
10 Aug
4
Statement of changes in beneficial ownership
7 Aug
4
Statement of changes in beneficial ownership
7 Aug
Beneficial Ownership
(177)
Expand
SC 13G
KLA CORP
30 Apr
SC 13G/A
KLA CORP
27 Mar
SC 13G/A
KLA CORP
4 Oct 2024
SC 13G/A
KLA CORP
13 Feb 2024
SC 13G/A
KLA CORP
25 Jan 2024
SC 13G/A
KLA CORP
13 Feb 2023
SC 13G/A
KLA CORP
9 Feb 2023
SC 13G
KLA CORP
30 Jan 2023
SC 13G/A
KLA CORP
11 Feb 2022
SC 13G/A
KLA CORP
10 Feb 2022
SC 13G/A
KLA CORP
10 Feb 2022
SC 13G/A
KLA CORP
8 Feb 2022
SC 13G/A
KLA CORP
1 Feb 2022
SC 13G
KLA CORP
16 Feb 2021
SC 13G/A
KLA CORP
12 Feb 2021
Other Ownership
(86)
Expand
144
WALLACE RICHARD P
15 Sep
144
Lorig Brian
13 Aug
144
Higgins Bren D.
12 Aug
144
Khan Ahmad A.
11 Aug
144
WALLACE RICHARD P
11 Aug
144
Wilkinson Mary Beth
10 Aug
144
Kirloskar Virendra A
10 Aug
144
Wilkinson Mary Beth
7 Aug
144
Kirloskar Virendra A
7 Aug
144
Wilkinson Mary Beth
5 Aug
144
Kirloskar Virendra A
5 Aug
144
Kirloskar Virendra A
4 Aug
144
Wilkinson Mary Beth
4 Aug
144/A
Higgins Bren D.
2 Jul
144
Kirloskar Virendra A
2 Jul
Proxies
(74)
Expand
ARS
Annual report to security holders
22 Sep
DEFA14A
Definitive additional materials
22 Sep
DEF 14A
Definitive proxy statement
22 Sep
ARS
Annual report to security holders
23 Sep 2025
DEF 14A
Definitive proxy statement
23 Sep 2025
DEFA14A
Definitive additional materials
23 Sep 2025
DEFA14A
Definitive additional materials
24 Sep 2024
DEF 14A
Definitive proxy statement
24 Sep 2024
ARS
Annual report to security holders
24 Sep 2024
ARS
Annual report to security holders
21 Sep 2023
DEF 14A
Definitive proxy statement
21 Sep 2023
DEFA14A
Definitive additional materials
21 Sep 2023
DEFA14A
Definitive additional materials
21 Oct 2022
DEFA14A
Definitive additional materials
11 Oct 2022
PX14A6G
Notice of exempt solicitation
6 Oct 2022
Registrations
(139)
Expand
S-8
Registration statement (employee benefit plan)
7 Nov 2025
S-8
Registration statement (employee benefit plan)
7 Nov 2024
424B5
Prospectus filing (Rule 424(b)(5))
1 Feb 2024
FWP
Free writing prospectus
30 Jan 2024
424B5
Prospectus filing (Rule 424(b)(5))
30 Jan 2024
S-8
Registration statement (employee benefit plan)
1 Nov 2023
S-8
Registration statement (employee benefit plan)
3 Feb 2023
424B5
Prospectus filing (Rule 424(b)(5))
23 Jun 2022
FWP
Free writing prospectus
21 Jun 2022
424B5
Prospectus filing (Rule 424(b)(5))
21 Jun 2022
S-8
Registration statement (employee benefit plan)
9 Jun 2022
S-3ASR
Automatic shelf registration statement (S-3)
9 Jun 2022
S-8
Registration statement (employee benefit plan)
7 Aug 2020
424B5
Prospectus filing (Rule 424(b)(5))
21 Feb 2020
FWP
Free writing prospectus
19 Feb 2020
Filing Review Correspondence
(1)
Expand
CORRESP
Filing review correspondence
6 Jun 2018
SEC Orders And Notices
(12)
Expand
EFFECT
Notice of effectiveness
7 Jun 2018
CT ORDER
Confidential treatment order
11 May 2018
CT ORDER
Confidential treatment order
9 May 2017
CT ORDER
Confidential treatment order
14 Nov 2016
CT ORDER
Confidential treatment order
9 Nov 2015
CT ORDER
Confidential treatment order
9 Dec 2014
CT ORDER
Confidential treatment order
12 Dec 2013
CT ORDER
Confidential treatment order
14 Mar 2013
CT ORDER
Confidential treatment order
23 Nov 2011
CT ORDER
Confidential treatment order
22 Nov 2010
CT ORDER
Confidential treatment order
18 Nov 2009
CT ORDER
Confidential treatment order
6 Jan 2009
Tender Offers And Going Private
(16)
Expand
SC TO-I/A
AMENDMENT NO. 1 TO SCHEDULE TO-I
18 Jun 2007
SC TO-T/A
AMENDMENT TO SCHEUDLE TO-T
25 May 2007
SC TO-T/A
AMENDMENT TO SCHEUDLE TO-T
18 May 2007
SC TO-I
SCHEDULE TO-I
16 May 2007
SC TO-T/A
AMENDMENT TO SHCEUDLE TO-T
14 May 2007
SC TO-T/A
AMENDMENT TO SCHEDULE TO-T
17 Apr 2007
SC TO-I/A
AMENDMENT NO. 5 TO SC TO ISSUER TENDER OFFER SUBJECT TO RULE 13E-4
29 Mar 2007
SC TO-I/A
AMENDMENT NO. 4 TO SC TO ISSUER TENDER OFFER SUBJECT TO RULE 13E-4
22 Mar 2007
SC TO-I/A
AMENDMENT NO. 3 TO SC TO ISSUER TENDER OFFER SUBJECT TO RULE 13E-4
16 Mar 2007
SC TO-T/A
AMENDMENT TO SCHEDULE TO-T
15 Mar 2007
SC TO-I/A
AMENDMENT NO. 2 TO SC TO ISSUER TENDER OFFER SUBJECT TO RULE 13E-4
13 Mar 2007
SC TO-I/A
AMENDMENT NO. 1 TO SC TO ISSUER TENDER OFFER SUBJECT TO RULE 13E-4
2 Mar 2007
SC TO-I
ISSUER TENDER OFFER
27 Feb 2007
SC TO-T/A
AMENDMENT TO SCHEDULE TO
13 Feb 2007
SC TO-C
PRELIMINARY COMMUNICATIONS TO TENDER OFFER
29 Jan 2007
Other
(16)
Expand
SD
SD
26 May
SD
SD
23 May 2025
SD
SD
24 May 2024
SD
SD
23 May 2023
SD
SD
27 May 2022
SD
SD
27 May 2021
SD
SD
21 May 2020
SD
SD
23 May 2019
SD
SD
23 May 2018
SD
SD
26 May 2017
SD
SD
27 May 2016
SD
SD
28 May 2015
SD
SD
2 Jun 2014
10-C
10-C
13 Feb 1996
10-C
10-C
26 Apr 1995
Ask in Filing
